News
1d
Game Rant on MSNDark Souls Fan Shows Off Mimic CosplayA Dark Souls fan is receiving plenty of online attention for their impressively detailed cosplay of a Mimic from Dark Souls 3 ...
Forbes contributors publish independent expert analyses and insights. Sughnen Yongo is a Midwest writer covering Black women, pop culture. There has always been something deliberate and quietly ...
Nowhere is this clearer than in the story of Black American tailoring and the legacy of the Black dandy. Inspired by scholar Monica L. Miller’s groundbreaking book Slaves to Fashion: Black ...
This year’s Met Gala is honoring Black fashion for the first time in its 77-year history. It’s an indirect celebration to be sure. Although the Costume Institute’s Spring 2025 exhibition ...
Hosted on MSN1mon
Jones Trading Downgrades Regulus Therapeutics (RGLS)Fintel reports that on April 30, 2025, Jones Trading downgraded their outlook for Regulus Therapeutics (NasdaqCM:RGLS) from Buy to Hold. Analyst Price Forecast Suggests 50.83% Upside As of April ...
Novartis plans to acquire clinical stage biotech Regulus Therapeutics in a deal worth up to $1.7 billion. Under the terms announced April 30, the Swiss drugmaker will make an upfront payment of $ ...
Novartis NOVN-0.76%decrease; red down pointing triangle has agreed to acquire Regulus Therapeutics RGLS 0.25%increase; green up pointing triangle for a total equity value of up to roughly $1.7 ...
Novartis AG agreed to buy US biotech Regulus Therapeutics Inc. in a deal that could be valued at up to $1.7 billion. The Swiss company will pay $7 a share in cash upfront through a subsidiary ...
Novartis' established global development and commercial capabilities will enable this important new medicine to reach patients if approved," said Jay Hagan, CEO of Regulus Therapeutics.
Novartis has agreed to acquire Regulus Therapeutics for a total equity value of up to roughly $1.7 billion. With the merger, the Swiss pharmaceutical company aims to bring to more patients ...
You can reach Jason on Signal at JasonMast.05. Novartis said Wednesday it would buy Regulus Therapeutics and its experimental kidney drug for $800 million upfront. The immediate payout is more ...
The silence of Black MAGA supporters in the face of Trump’s and Vance’s bigotry during the campaign has carried over to the second Trump era. Representative Byron Donalds stands in the crowd ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results